Maven Brands Inc (TRLFF)
0.01
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Maven Brands Total Liabilities (Quarterly): 5.019M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 5.019M |
September 30, 2022 | 5.363M |
June 30, 2022 | 5.409M |
March 31, 2022 | 5.278M |
December 31, 2021 | 5.041M |
September 30, 2021 | 4.214M |
June 30, 2021 | 4.448M |
March 31, 2021 | 4.125M |
December 31, 2020 | 4.359M |
September 30, 2020 | 7.045M |
June 30, 2020 | 6.706M |
March 31, 2020 | 5.523M |
December 31, 2019 | 4.678M |
September 30, 2019 | 3.984M |
June 30, 2019 | 3.662M |
March 31, 2019 | 4.095M |
Date | Value |
---|---|
December 31, 2018 | 1.432M |
September 30, 2018 | 1.719M |
June 30, 2018 | 0.8587M |
March 31, 2018 | 0.813M |
December 31, 2017 | 0.2729M |
September 30, 2017 | 0.3112M |
March 31, 2017 | 0.2586M |
December 31, 2016 | 0.2608M |
September 30, 2016 | 0.2147M |
June 30, 2016 | 0.1184M |
March 31, 2016 | 0.4769M |
December 31, 2015 | 0.3957M |
September 30, 2015 | 0.2832M |
June 30, 2015 | 0.2103M |
March 31, 2015 | 0.1223M |
December 31, 2014 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.662M
Minimum
Jun 2019
7.045M
Maximum
Sep 2020
4.990M
Average
5.019M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.725M |
Shareholders Equity (Quarterly) | -1.294M |